Flag of the European Union EU Clinical Trials Register Help

Clinical trials for IVF

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    131 result(s) found for: IVF. Displaying page 1 of 7.
    1  2  3  4  5  6  7  Next»
    EudraCT Number: 2004-001124-20 Sponsor Protocol Number: PCOS-5 Start Date*: 2005-04-18
    Sponsor Name:Sigrun Kjøtrød
    Full Title: Metformin treatment before IVF/ICSI in normal weight women with polycystic ovarian syndrome. A European, prospective, randomised, double blind, multicenter study.
    Medical condition: Polycystic ovary syndrome (PCOS) is a disorder characterized by polycystic ovaries, oligo-amenorrhea and hyperandrogenism. It is the most common endocrine disorder in women of fertile age. PCOS wom...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed) SE (Completed) FI (Completed) GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-000500-13 Sponsor Protocol Number: 8821 Start Date*: 2005-08-15
    Sponsor Name:University of Oxford- Research Services
    Full Title: Metformin treatment before IVF in women with ultrasound evidence of polycystic ovaries; a prospective, randomised, double blind, placebo controlled study
    Medical condition: Infertile women undergoing IVF with sonographic evidence of polycystic ovaries but without any clinical manifestations of polycystic ovarian syndrome.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2017-002936-17 Sponsor Protocol Number: LIV001 Start Date*: 2019-02-22
    Sponsor Name:Livio Falun
    Full Title: Treatment with intralipid in assisted fertilization
    Medical condition: Infertility conditions that required IVF treatment Male infertility Endometrosis PCOS uNEXPLAINED INFERTILITY Tubal damage
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-010952-81 Sponsor Protocol Number: OG08/8802 Start Date*: 2009-08-17
    Sponsor Name:Leeds Teaching Hospitals NHS Trust
    Full Title: The use of Metformin and Gonadotrophin Releasing Hormone Antagonist for the treatment of women with Polycystic Ovary Syndrome undergoing In-vitro Fertilisation-Embryo Transfer.
    Medical condition: Polycystic ovary syndrome.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2016-004545-91 Sponsor Protocol Number: 59874 Start Date*: 2017-04-13
    Sponsor Name:VU University Medical Center, department of reproductive Medicine
    Full Title: Continuous use of Oral contraceptives as an alternative for long term Pituitary down-regulation with GnRH agonist prior to IVF/ICSI in Endometriosis patients: a randomised controlled trial (COPIE t...
    Medical condition: The research population consists of women with surgically confirmed endometriosis ASRM stage III or IV or endometrioma on transvaginal ultrasound or MRI, scheduled for an IVF/ICSI treatment.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-000689-13 Sponsor Protocol Number: HRT1vs2week.2018 Start Date*: 2018-07-11
    Sponsor Name:University hospital Brussel
    Full Title: Clinical pregnancy rate for frozen embryo transfer with HRT: a pilot study comparing 1 versus 2 weeks of treatment
    Medical condition: Subfertility in need of IVF and IVF-ICSI treatment
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004872 10042391 Subfertility LLT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-003104-11 Sponsor Protocol Number: 1.0 Start Date*: 2005-10-11
    Sponsor Name:Fertility clinic Odense University Hospital
    Full Title: Androgen priming in the late luteal phase as a mean to improve the outcome of ovarian stimulation for IVF in normogonadotrophic women with a previously proven poor response
    Medical condition: Hypothesis. By combining pituitary downregulation with aromatase inhibitor, and hCG injection during a late luteal phase a powerful stimulation of thecal androgen production is achieved. Thereby, i...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-001708-39 Sponsor Protocol Number: S54224 Start Date*: 2012-06-07
    Sponsor Name:University Hospital Leuven
    Full Title: Prospective randomized trial concerning three different stimulation methods in IVF/ICSI treatment in poor responders
    Medical condition: Subfertility
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038604 - Reproductive system and breast disorders 10016465 Fertility female decreased LLT
    14.1 10038604 - Reproductive system and breast disorders 10016398 Female infertility LLT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2016-004266-25 Sponsor Protocol Number: 16-OBE001-005 Start Date*: 2017-02-24
    Sponsor Name:ObsEva S.A.
    Full Title: A phase 3, double-blind, randomized, placebo-controlled study to assess the safety and efficacy of a single oral administration of nolasiban to improve pregnancy rates following IVF or ICSI in Day ...
    Medical condition: Embryo implantation in women undergoing IVF or ICSI with Day 3 or Day 5 fresh embryo transfer cycles, in the context of Assisted Reproductive Technology (ART).
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10073184 Embryo transfer LLT
    Population Age: Adults Gender: Female
    Trial protocol: CZ (Completed) DE (Completed) DK (Completed) BE (Completed) HU (Completed) EE (Completed) ES (Completed) FI (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2016-002385-31 Sponsor Protocol Number: 2015/582 Start Date*: 2017-08-28
    Sponsor Name:Professor Peter Humaidan, The Fertility Clinic Skive
    Full Title: A double-blind, placebo-controlled multicenter trial on the effect of clindamycin and a live biotherapeutic on the reproductive outcomes of IVF patients with abnormal vaginal microbiota
    Medical condition: Infertility
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004865 10021572 In vitro fertilization LLT
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2018-002910-11 Sponsor Protocol Number: 18-OBE001-010 Start Date*: 2018-11-08
    Sponsor Name:ObsEva SA
    Full Title: A phase 3, double-blind, randomized, placebo-controlled study to assess the safety and efficacy of a single oral administration of nolasiban to increase ongoing pregnancy rate following fresh singl...
    Medical condition: Embryo implantation in women undergoing IVF with Day 5 fresh embryo transfer cycles
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10073184 Embryo transfer LLT
    Population Age: Adults Gender: Female
    Trial protocol: HU (Completed) DK (Completed) ES (Ongoing) BE (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2005-000993-29 Sponsor Protocol Number: 04I/HMG10 Start Date*: 2005-07-19
    Sponsor Name:IBSA
    Full Title: A prospective, randomized, investigator-blind, controlled, clinical study of phase III on the clinical efficacy and tolerability of hMG-IBSA IBSA Institut Biochimique sa versus Menopur Ferring ...
    Medical condition: COH Controlled Ovarian Hyperstimulation in ART Assisted Reproductive Technology /IVF
    Disease: Version SOC Term Classification Code Term Level
    6.1 10056204 PT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2006-000014-20 Sponsor Protocol Number: PV_IVF-01-05_CYT Start Date*: 2006-04-05
    Sponsor Name:CYTOCHEMIA AG
    Full Title: Prospective, double-blind, randomized, placebo-controlled, parallel group, multi-centre phase III study to evaluate the efficacy and safety of a human leukocytic ultrafiltrate (Leukonorm Cytochemia...
    Medical condition: female patients with repetitive implantation failures during previous IVF/ICSI-cycles
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2004-002623-41 Sponsor Protocol Number: endo 220604 Start Date*: 2004-09-10
    Sponsor Name:Anders Nyboe Andersen, klinikchef, dr. med., Fertilitetsklinikken afsnit 4071, Rigshospitalet
    Full Title: Anvendelse af aromatase-inhibitor (Arimidex) i kombination med GnRH agonist (Zoladex) som forbehandling til IVF hos patienter med ovariel endometriose
    Medical condition: endometriosis ovarii
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-004954-27 Sponsor Protocol Number: Start Date*: 2012-12-07
    Sponsor Name:Clinical Trials and Research Governance, University of Oxford
    Full Title: A single centre open-label randomised controlled trial of long term pituitary down-regulation before in vitro fertilisation for women with endometriosis: a pilot study
    Medical condition: Sub-infertility due to endometriosis
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004872 10016402 Female infertility of pituitary-hypothalamic origin LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-006595-11 Sponsor Protocol Number: 07EU/Prg06 Start Date*: 2008-09-25
    Sponsor Name:IBSA Institut Biochimique SA
    Full Title: Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone Gel (Crinone) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF).
    Medical condition: Patient undergoing in-Vitro Fertilization (IVF)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10021572 In vitro fertilization LLT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) HU (Completed) GB (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2020-001069-35 Sponsor Protocol Number: IIBSP-EDA-2020-18 Start Date*: 2021-07-06
    Sponsor Name:Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau – IIB Sant Pau
    Full Title: Impact of Exercise and Mediterranean diet vs Aspirin on live-birth rate and cardiovascular programming in In Vitro Fertilization (MEDITATE-IVF): a Randomized Study.
    Medical condition: Cumulative live-birth rate.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2018-002000-13 Sponsor Protocol Number: rFSHdosingfinding.2018 Start Date*: 2019-01-09
    Sponsor Name:University hospital Brussel
    Full Title: Effect of recombinant FSH dosing following corifollitropin alfa in patients undergoing IVF/ICSI in a GnRH antagonist protocol: a randomized controlled dose-finding study.
    Medical condition: Subfertility in need of IVF and IVF-ICSI treatment
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004872 10042392 Subfertility (female) LLT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2006-004460-31 Sponsor Protocol Number: PRINT Start Date*: 2007-02-21
    Sponsor Name:Guy's & St Thomas' NHS Foundation Trust
    Full Title: A randomised controlled trial comparing the gonadotrophin releasing hormone (GnRH) agonist long regimen versus the GnRH agonist short regimen versus the GnRH antagonist regimen in poor responders u...
    Medical condition: Poor ovarian response in women undergoing In vitro Fertilisation (IVF) treatment.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10056204 In vitro fertilisation PT
    Population Age: Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2010-019411-37 Sponsor Protocol Number: FE999906CS11 Start Date*: 2010-08-30
    Sponsor Name:FERRING Arzneimittel GmbH
    Full Title: A Prospective, Open Label, Randomised, Parallel Group Trial Comparing the Effects of Highly Purified Menotrophin and Recombinant Follicle Stimulating Hormone (rFSH, Follitropin alpha) Administered ...
    Medical condition: Controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies
    Disease: Version SOC Term Classification Code Term Level
    14.0 10038604 - Reproductive system and breast disorders 10021926 Infertility PT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 17 18:45:35 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA